TargetMol

Bremelanotide Acetate

Product Code:
 
TAR-T7608
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7608-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7608-1mL1 mL * 10 mM (in DMSO)£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7608-25mg25mg£137.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7608-50mg50mg£182.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7608-100mg100mg£237.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Bremelanotide is an agonist of melanocortin receptor (MCR) .
CAS:
1607799-13-2
Formula:
C52H72N14O12
Molecular Weight:
1085.234
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.98
SMILES:
CC(O)=O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)C(O)=O
Target:
Melanocortin Receptor

References

Pfaus JG, Shadiack A, Van Soest T,et al.Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist[J].Proc Natl Acad Sci U S A. 2004 Jul 6;101(27) Clayton AH, Althof SE, Kingsberg S,et al.Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial[J].Womens Health (Lond). 2016 Jun;12(3):325-37.